Address: 3rd Flr DOST Main Building, Gen. Santos Ave., Bicutan, Taguig City 1631,Philippines
Tel: +632 837-7534
Web: http://www.pchrd.dost.gov.ph/
The Philippine Council for Health Research and Development (PCHRD) is one of the five sectoral councils of the Department of Science and Technology (DOST). PCHRD is a forward-looking, partnership-based national body responsible for coordinating and monitoring health research activities in the country. Since its founding on 17 March 1982 through Executive Order No.784, PCHRD has brought technical excellence with a soul into fulfilling its mandate.
The primordial source of health research leadership and direction in the country, PCHRD resolves to foster healthier and more productive lives among the Filipinos through health research and development (R&D).
As the focal point for health research and development (R&D) in the country:
1. We provide leadership and direction in health and related R&D activities
2. We rationalize investment in science and technology through a system of review of ongoing and pipeline projects in the government sector, and by influencing the private sector to support and implement projects that are in consonance with the Health Science and Technology Plan
3. We develop and strengthen human and infrastructure resources of the health research network
4. We implement a research utilization program to ensure that research products are properly disseminated among and utilized by their intended users
5. We facilitate the identification and packaging of health technologies for adoption and commercialization by both government and private sectors
6. We generate additional resources for health R&D by pursuing active collaboration with local and international funding agencies
Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are…
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant challenge to the innovative medicines industry but also…
“The IMS Health figures show around three to four percent growth in the marketplace,” remarks Raymund Azurin, chief executive of Zuellig Pharma Philippines, “but we are now at a…
Before the introduction of universal healthcare (UHC), most major private hospitals in the Philippines had to rely on imported products. With the MNCs showing only limited interest in small volumes,…
The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal…
Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major…
Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges…
Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and…
Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall…
Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines,…
Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
See our Cookie Privacy Policy Here
